Regeneron Pharmaceuticals, Inc. (REGN)
NASDAQ: REGN · Real-Time Price · USD
603.58
-2.03 (-0.34%)
May 5, 2025, 4:00 PM EDT - Market closed
Regeneron Pharmaceuticals (REGN) Revenue by Segment
History
Date | Collaboration | Net Product | Other |
---|---|---|---|
Mar 31, 2025 | 6.32B | 7.28B | 480.00M |
Dec 31, 2024 | 6.06B | 7.63B | 515.00M |
Sep 30, 2024 | 5.82B | 7.48B | 548.10M |
Jun 30, 2024 | 5.60B | 7.32B | 572.20M |
Mar 31, 2024 | 5.39B | 7.17B | 537.00M |
Dec 31, 2023 | 5.50B | 7.08B | 536.10M |
Sep 30, 2023 | 5.72B | 6.93B | 451.30M |
Jun 30, 2023 | 5.33B | 6.94B | 397.20M |
Mar 31, 2023 | 5.06B | 6.92B | 387.10M |
Dec 31, 2022 | 4.91B | 6.89B | 365.10M |
Sep 30, 2022 | 4.22B | 9.17B | 323.60M |
Jun 30, 2022 | 4.24B | 9.65B | 338.40M |
Mar 31, 2022 | 4.15B | 12.03B | 325.20M |
Dec 31, 2021 | 3.67B | 12.12B | 281.20M |
Sep 30, 2021 | 3.46B | 9.76B | 318.40M |
Jun 30, 2021 | 3.04B | 8.97B | 378.00M |
Mar 31, 2021 | 2.60B | 6.06B | 543.80M |
Dec 31, 2020 | 2.37B | 5.57B | 557.00M |
Sep 30, 2020 | 2.18B | 5.23B | 529.10M |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.